| Laura Kimball-ravari, MD | |
|
2449 Hospital Dr, Suite 400, Bossier City, LA 71111-2399 | |
| (318) 212-7902 | |
| (318) 212-7905 |
| Full Name | Laura Kimball-ravari |
|---|---|
| Gender | Female |
| Speciality | Endocrinology |
| Experience | 25 Years |
| Location | 2449 Hospital Dr, Bossier City, Louisiana |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1861437543 | NPI | - | NPPES |
| 1423190 | Medicaid | LA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RE0101X | Internal Medicine - Endocrinology, Diabetes & Metabolism | 026731 (Louisiana) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Willis Knighton Medical Center, Inc | Shreveport, LA | Hospital |
| Springhill Medical Center | Springhill, LA | Hospital |
| Jackson Parish Hospital | Jonesboro, LA | Hospital |
| North Caddo Medical Center | Vivian, LA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Wk Endocrine Specialists | 6406980689 | 8 |
News Archive
RetroVirox, Inc., a biotechnology company specializing in the development of novel antivirals, announced today that it has received a grant award of $296,875 from the National Institute of Allergy and Infectious Disease (NIAID), of the National Institutes of Health (NIH). This is the second award to RetroVirox from the NIH in less than six months. In March 2009 the company received its first grant to develop novel inhibitors of HIV entry.
A national team of researchers led by scientists at Mayo Clinic has found that a common treatment for primary sclerosing cholangitis, a chronic liver disease, is not helpful for patients, according to a study published this month in the journal Hepatology.
According to a study published in Nature Biotechnology, the sVNT is capable of detecting the functional neutralizing antibodies (NAbs) that can block the binding of the coronavirus spike protein to the angiotensin-converting enzyme 2 (ACE2) host receptor, which mimics the virus-host interaction.
Emmanuel Njeuhmeli, a senior biomedical prevention advisor in the USAID Office of HIV/AIDS, discusses efforts to raise awareness about male circumcision as a "cost saving and effective form of HIV prevention" in a post on USAID's "Impact Blog."
News-Medical speaks to Dr. Tanya Altmann about her latest partnership with Duracell that is encouraging people to learn about lithium coin battery safety.
› Verified 7 days ago
| Entity Name | Wk Endocrine Specialists |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1073831004 PECOS PAC ID: 6406980689 Enrollment ID: O20100811000036 |
News Archive
RetroVirox, Inc., a biotechnology company specializing in the development of novel antivirals, announced today that it has received a grant award of $296,875 from the National Institute of Allergy and Infectious Disease (NIAID), of the National Institutes of Health (NIH). This is the second award to RetroVirox from the NIH in less than six months. In March 2009 the company received its first grant to develop novel inhibitors of HIV entry.
A national team of researchers led by scientists at Mayo Clinic has found that a common treatment for primary sclerosing cholangitis, a chronic liver disease, is not helpful for patients, according to a study published this month in the journal Hepatology.
According to a study published in Nature Biotechnology, the sVNT is capable of detecting the functional neutralizing antibodies (NAbs) that can block the binding of the coronavirus spike protein to the angiotensin-converting enzyme 2 (ACE2) host receptor, which mimics the virus-host interaction.
Emmanuel Njeuhmeli, a senior biomedical prevention advisor in the USAID Office of HIV/AIDS, discusses efforts to raise awareness about male circumcision as a "cost saving and effective form of HIV prevention" in a post on USAID's "Impact Blog."
News-Medical speaks to Dr. Tanya Altmann about her latest partnership with Duracell that is encouraging people to learn about lithium coin battery safety.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Laura Kimball-ravari, MD 2449 Hospital Dr, Suite 400, Bossier City, LA 71111-2399 Ph: (318) 212-7902 | Laura Kimball-ravari, MD 2449 Hospital Dr, Suite 400, Bossier City, LA 71111-2399 Ph: (318) 212-7902 |
News Archive
RetroVirox, Inc., a biotechnology company specializing in the development of novel antivirals, announced today that it has received a grant award of $296,875 from the National Institute of Allergy and Infectious Disease (NIAID), of the National Institutes of Health (NIH). This is the second award to RetroVirox from the NIH in less than six months. In March 2009 the company received its first grant to develop novel inhibitors of HIV entry.
A national team of researchers led by scientists at Mayo Clinic has found that a common treatment for primary sclerosing cholangitis, a chronic liver disease, is not helpful for patients, according to a study published this month in the journal Hepatology.
According to a study published in Nature Biotechnology, the sVNT is capable of detecting the functional neutralizing antibodies (NAbs) that can block the binding of the coronavirus spike protein to the angiotensin-converting enzyme 2 (ACE2) host receptor, which mimics the virus-host interaction.
Emmanuel Njeuhmeli, a senior biomedical prevention advisor in the USAID Office of HIV/AIDS, discusses efforts to raise awareness about male circumcision as a "cost saving and effective form of HIV prevention" in a post on USAID's "Impact Blog."
News-Medical speaks to Dr. Tanya Altmann about her latest partnership with Duracell that is encouraging people to learn about lithium coin battery safety.
› Verified 7 days ago
Neelima Chintapalli, M.D. Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 2539 Viking Dr, Bossier City, LA 71111 Phone: 318-848-2970 Fax: 318-848-2971 | |
Diana Magpayo Lim, MD Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 2400 Hospital Dr, Suite 420, Bossier City, LA 71111 Phone: 318-212-7910 Fax: 318-212-7915 | |
Dr. Barry Marvin Osherowitz, MD Endocrinology, Diabetes & Metabolism Medicare: Medicare Enrolled Practice Location: 1608 Jimmie Davis Hwy, Bossier City, LA 71112 Phone: 318-747-2510 Fax: 318-742-3727 | |
Nealan Dewayne Prather, MD Endocrinology, Diabetes & Metabolism Medicare: Not Enrolled in Medicare Practice Location: 2400 Hospital Dr, Suite 420, Bossier City, LA 71111 Phone: 318-212-7910 Fax: 318-212-7915 | |
Leslie Jean Sewell, MD Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 2300 Hospital Dr, Suite 320, Bossier City, LA 71111 Phone: 318-212-7848 Fax: 318-212-7855 | |
Tom Chalermchai Rodsuwan, MD Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 2400 Hospital Dr, Suite 130, Bossier City, LA 71111 Phone: 318-212-7990 Fax: 318-212-7995 | |
Charles Alfred Powers, MD Endocrinology, Diabetes & Metabolism Medicare: Not Enrolled in Medicare Practice Location: 2400 Hospital Dr, Suite 420, Bossier City, LA 71111 Phone: 318-212-7910 Fax: 318-212-7915 |